SURVIVAL PLUSS: Increasing Capacity for Mama-baby Survival in Post-conflict Uganda and South Sudan

NCT02605369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1877

Last updated 2023-10-10

No results posted yet for this study

Summary

Universal coverage of good quality facility based care globally could prevent nearly 113,000 maternal deaths, 531,000 stillbirths and 1.3 million neonatal deaths annually by 2020. Yet, only 57% of pregnant Ugandan women choose to deliver at health facilities. This unacceptably low coverage of facility based births could explain, in part, the high maternal and perinatal mortality estimates in Uganda. While multiple studies have examined factors associated with this low utilization of health services around the time of birth, there is inadequate implementation research exploring the best systematic methods that could promote uptake and scale up of facility based births. This study will therefore examine the effect of an intervention package (peer counselling by pregnancy buddies on facility based births, mobile phone messaging promoting facility based births and provision of mama-kits) on the frequency of facility based births and perinatal mortality. The study, a cluster randomized community based intervention trial in post-conflict Northern Uganda, will provide data crucial in framing national policy regarding measures to promote the use of health facilities.

Conditions

  • Neonatal Death
  • Preterm Birth
  • Low Birthweight
  • Neonatal Hypoglycemia

Interventions

BEHAVIORAL

Intervention arm: An integrated package

See description in previous column

Sponsors & Collaborators

  • Centre For International Health

    collaborator OTHER
  • Makerere University

    lead OTHER

Principal Investigators

  • Victoria Nankabirwa, MD, MPH, PhD · Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Makerere University

  • James K Tumwine, MD, PhD · Makerere University

  • Grace Ndeezi, MD, PhD · Makerere Univeristy

  • Thorkild Tylleskar, MD, PhD · University of Bergen

  • Paul Wako, MD, PhD · Busitema University

  • Joyce Kaducu · Gulu University

  • Jino Meleby · University of Juba

  • Frederik Froen, MD, PhD · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02605369 on ClinicalTrials.gov